These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3468284

  • 1. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR, Hoffman LH, Snyder F.
    Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
    [Abstract] [Full Text] [Related]

  • 3. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
    Lu X, Arthur G.
    Cancer Res; 1992 May 15; 52(10):2813-7. PubMed ID: 1581895
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE, Greiner E, Fink U, Stavrou D, Reichert A, Rastetter J, Hoffman DR, Snyder F.
    Cancer Res; 1983 Feb 15; 43(2):541-5. PubMed ID: 6848177
    [Abstract] [Full Text] [Related]

  • 5. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 6. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
    Lu X, Arthur G.
    Cancer Res; 1992 May 15; 52(10):2806-12. PubMed ID: 1581894
    [Abstract] [Full Text] [Related]

  • 7. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M, Fukuhara T, Winton EF, Berdel WE, Vogler WR.
    Exp Hematol; 1994 Jan 15; 22(1):13-8. PubMed ID: 8282054
    [Abstract] [Full Text] [Related]

  • 8. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
    Storme GA, Berdel WE, van Blitterswijk WJ, Bruyneel EA, De Bruyne GK, Mareel MM.
    Cancer Res; 1985 Jan 15; 45(1):351-7. PubMed ID: 4038380
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D, Berkovic K, Fleer EA, Eibl H, Unger C.
    Eur J Cancer; 1994 May 15; 30A(4):509-15. PubMed ID: 8018410
    [Abstract] [Full Text] [Related]

  • 11. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
    Kosano H, Takatani O.
    Cancer Res; 1989 Jun 01; 49(11):2868-70. PubMed ID: 2785846
    [Abstract] [Full Text] [Related]

  • 12. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H, Takatani O.
    Cancer Res; 1988 Nov 01; 48(21):6033-6. PubMed ID: 3262419
    [Abstract] [Full Text] [Related]

  • 13. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC, Small WC, Brynes RK, Tidwell T, Goldstein JH, Vogler WR.
    Cancer Res; 1983 Feb 01; 43(2):770-5. PubMed ID: 6571718
    [Abstract] [Full Text] [Related]

  • 14. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F, Daniel LW.
    Cancer Chemother Pharmacol; 1998 Feb 01; 42(4):319-26. PubMed ID: 9744778
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR, Bittman R, Peters A, Mayhew E.
    J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H, Yasutomo Y, Kugai N, Nagata N, Inagaki H, Tanaka S, Takatani O.
    Cancer Res; 1990 Jun 01; 50(11):3172-5. PubMed ID: 2334912
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA, Buettner GR, Oberley LW, Burns CP.
    Cancer Res; 1998 Jul 01; 58(13):2809-16. PubMed ID: 9661895
    [Abstract] [Full Text] [Related]

  • 18. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
    Vogler WR, Whigham E, Bennett WD, Olson AC.
    Exp Hematol; 1985 Aug 01; 13(7):629-33. PubMed ID: 3861326
    [Abstract] [Full Text] [Related]

  • 19. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW, Civoli F, Rogers MA, Smitherman PK, Raju PA, Roederer M.
    Cancer Res; 1995 Nov 01; 55(21):4844-9. PubMed ID: 7585518
    [Abstract] [Full Text] [Related]

  • 20. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T, Sieber F.
    Bone Marrow Transplant; 1997 Jan 01; 19(2):113-9. PubMed ID: 9116607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.